Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/152378
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRequena-Méndez, Ana-
dc.contributor.authorSalas-Coronas, Joaquín-
dc.contributor.authorSalvador, Fernando-
dc.contributor.authorGómez Junyent, Joan-
dc.contributor.authorVillar Garcia, Judith-
dc.contributor.authorSantín Cerezales, Miguel-
dc.contributor.authorMuñoz, Carmen-
dc.contributor.authorGonzález Cordón, Ana-
dc.contributor.authorCabezas Fernández, Maria Teresa-
dc.contributor.authorSulleiro, Elena-
dc.contributor.authorArenas-Miras, Maria del Mar-
dc.contributor.authorSomoza, Dolors-
dc.contributor.authorVazquez Villegas, Jose-
dc.contributor.authorTreviño, Begoña-
dc.contributor.authorRodríguez de las Parras, Esperanza-
dc.contributor.authorValls, M. Eugenia-
dc.contributor.authorLlaberia Marcual, Jaume-
dc.contributor.authorSubirà, Carme-
dc.contributor.authorMuñoz, José-
dc.date.accessioned2020-03-10T09:28:30Z-
dc.date.available2020-03-10T09:28:30Z-
dc.date.issued2020-02-11-
dc.identifier.issn2076-0817-
dc.identifier.urihttps://hdl.handle.net/2445/152378-
dc.description.abstractIntroduction: Strongyloidiasis is a prevailing helminth infection ubiquitous in tropical and subtropical areas, however, seroprevalence data are scarce in migrant populations, particularly for those coming for Asia. Methods: This study aims at evaluating the prevalence of S. stercoralis at the hospital level in migrant populations or long term travellers being attended in out-patient and in-patient units as part of a systematic screening implemented in six Spanish hospitals. A cross-sectional study was conducted and systematic screening for S. stercoralis infection using serological tests was offered to all eligible participants. Results: The overall seroprevalence of S. stercoralis was 9.04% (95%CI 7.76–10.31). The seroprevalence of people with a risk of infection acquired in Africa and Latin America was 9.35% (95%CI 7.01–11.69), 9.22% (7.5–10.93), respectively. The number of individuals coming from Asian countries was significantly smaller and the overall prevalence in these countries was 2.9% (95%CI −0.3–6.2). The seroprevalence in units attending potentially immunosuppressed patients was significantly lower (5.64%) compared with other units of the hospital (10.20%) or Tropical diseases units (13.33%) (p < 0.001). Conclusions: We report a hospital-based strongyloidiasis seroprevalence of almost 10% in a mobile population coming from endemic areas suggesting the need of implementing strongyloidiasis screening in hospitalized patients coming from endemic areas, particularly if they are at risk of immunosuppression.-
dc.format.extent12 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherMDPI-
dc.relation.isformatofReproducció del document publicat a: http://dx.doi.org/10.3390/pathogens9020107-
dc.relation.ispartofPathogens, 2020, vol. 9, num. 2-
dc.relation.urihttp://dx.doi.org/10.3390/pathogens9020107-
dc.rightscc by (c) Requena-Méndez et al., 2020-
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/-
dc.sourceArticles publicats en revistes (Ciències Clíniques)-
dc.subject.classificationNematodes-
dc.subject.classificationMalalties parasitàries-
dc.subject.otherNematodes-
dc.subject.otherParasitic diseases-
dc.titleHigh Prevalence of Strongyloidiasis in Spain: A Hospital-Based Study-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec699637-
dc.date.updated2020-02-21T19:02:03Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid32053864-
Appears in Collections:Articles publicats en revistes (ISGlobal)
Articles publicats en revistes (Medicina)
Articles publicats en revistes (Ciències Clíniques)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
Requena-MendezA_Pathogens_2020.pdf729.85 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons